Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 148 Results

Title
Intervention Indication Therapeutic Area Year Actions
Nitazoxanide for treatment of common cold due to rhinovirus or other enterovirus infection Nitazoxanide (NT-300; NTZ; PH-5776) Common cold Infectious Disease 2021 View  |  Download
Nivolumab for adjuvant and neoadjuvant treatment of localised renal cell carcinoma Nivolumab (Opdivo; BMS-936558; ONO-4538) Renal cell carcinoma (RCC) Renal Cancer 2021 View  |  Download
Nivolumab for adjuvant treatment of stage IB-IIIA non-small cell lung cancer Nivolumab (Opdivo; BMS-936558; ONO-4538) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Nivolumab in combination with chemoradiotherapy for squamous cell head and neck cancer Cisplatin (Platinol) , Nivolumab (Opdivo; BMS-936558; ONO-4538) Head and neck cancer Head and Neck Cancer 2021 View  |  Download
Nivolumab in combination with ipilimumab for cisplatin-ineligible patients with untreated, unresectable or metastatic urothelial cancer– first line Ipilimumab (Yervoy; BMS 734016; MDX 101) , Nivolumab (Opdivo; BMS-936558; ONO-4538) Bladder cancer Oncology , Urological Cancer 2021 View  |  Download
Nivolumab in combination with ipilimumab for gastric or gastroesophageal junction cancer – first line Ipilimumab (Yervoy; BMS 734016; MDX 101) , Nivolumab (Opdivo; BMS-936558; ONO-4538) Gastric cancer Gastrointestinal Cancer 2021 View  |  Download
Nivolumab with docetaxel for advanced castration-resistant prostate cancer Docetaxel (Taxotere; docetaxel trihydrate; docetaxel anhydrous) , Nivolumab (Opdivo; BMS-936558; ONO-4538) Prostate cancer Male Reproductive Cancer 2021 View  |  Download
Parsaclisib for marginal zone lymphoma – relapsed or refractory Parsaclisib (INCB050465) Marginal zone lymphoma (MZL) Haematological Cancer and Lymphomas 2021 View  |  Download
Pegcetacoplan for treating geographic atrophy Pegcetacoplan (APL-2) Geographic atrophy Ophthalmology 2021 View  |  Download
Pegzilarginase for Arginase-1 deficiency Pegzilarginase (AEB1102; Loargys) Hyperargininemia Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
1 2 7 8 9 10 11 14 15
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications